Literature DB >> 10714945

Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.

D Dimitrijevic1, A J Shaw, A T Florence.   

Abstract

The effects of the non-ionic surfactants polysorbate 20, polysorbate 60, polysorbate 85, cholesteryl poly (24) oxyethylene ether (Solulan C24) and the lanolin-based poly (16) oxyethylene ether (Solulan 16) on the epithelial integrity of monolayers of human intestinal epithelial (Caco-2) cells has been studied using metformin as a model drug. The aim was to identify the surfactants and their optimal concentrations capable of enhancing drug transport while causing no, or only minor, cellular damage. Effects on cell permeability were assessed by measurements of the transport of metformin, a hydrophilic drug, by monitoring transepithelial electrical resistance. Cell viability was determined by the diphenyltetrazolium bromide test (the MTT test). All the surfactants studied demonstrated concentration-dependent effects on cell permeability and cell viability. The effects on transepithelial electrical resistance correlated with cell viability, i.e. increased transepithelial electrical resistance and increased cell-monolayer permeability for metformin corresponded to decreased cell viability. The results indicate that the Solulan and polysorbate surfactants were active as absorption enhancers, Solulan C24 and 16 being more effective than polysorbates 20, 60 or 85, causing an increase in metformin transport at lower concentrations than the polysorbates. Polysorbate 20 exerted its greatest effect at a concentration of 5%-increasing the flux of metformin after 3 h by a factor of around 20 over the control. Large increases in the transport of metformin, especially at surfactant levels of 0.05%, 0.1% and 0.5%, were related to the effect of Solulan C24 and Solulan 16 on the cell permeability. The Caco-2 cell monolayer experiments confirmed the ability, especially of polysorbate 20, Solulan C24 and Solulan 16, to increase the absorption of metformin. The polysorbates increased permeability as a result of solubilisation of membrane components, while Solulans did so by penetrating and solubilising the membrane. Correlation between increase in membrane permeability and the toxicity of the surfactants towards the cell membrane has been established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714945     DOI: 10.1211/0022357001773805

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  17 in total

Review 1.  Current industrial practices of assessing permeability and P-glycoprotein interaction.

Authors:  Praveen V Balimane; Yong-Hae Han; Saeho Chong
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

2.  A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug.

Authors:  Mohammed M Alvi; Parnali Chatterjee
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

3.  An Industrial Procedure for Pharmacodynamic Improvement of Metformin HCl via Granulation with Its Paracellular Pathway Enhancer Using Factorial Experimental Design.

Authors:  Omar Y Mady; Adam A Al-Shoubki; Ahmed A Donia
Journal:  Drug Des Devel Ther       Date:  2021-11-02       Impact factor: 4.162

4.  Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers.

Authors:  Carol L Roberts; Asa V Keita; Sylvia H Duncan; Niamh O'Kennedy; Johan D Söderholm; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2010-09-02       Impact factor: 23.059

5.  In vitro assessment of alkylglycosides as permeability enhancers.

Authors:  J G Eley; P Triumalashetty
Journal:  AAPS PharmSciTech       Date:  2001-10-19       Impact factor: 3.246

6.  Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.

Authors:  Anna Elgart; Irina Cherniakov; Yanir Aldouby; Abraham J Domb; Amnon Hoffman
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

7.  Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction.

Authors:  Ratnesh Kumar Singh; Nolan Wheildon; Seiichi Ishikawa
Journal:  SOJ Microbiol Infect Dis       Date:  2016-06-01

8.  Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation.

Authors:  Myoung-Ki Baek; Jong-Hwa Lee; Young-Ho Cho; Hak-Hyung Kim; Gye-Won Lee
Journal:  Int J Nanomedicine       Date:  2013-01-07

9.  Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor.

Authors:  Xiaoqin Wang; Weidong Xu; Subhra Mohapatra; Xiaoyuan Kong; Xu Li; Richard F Lockey; Shyam S Mohapatra
Journal:  Genet Vaccines Ther       Date:  2008-02-15

10.  Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations.

Authors:  Janneke Keemink; Christel A S Bergström
Journal:  Pharm Res       Date:  2018-02-26       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.